This item is authorised by the following title:
Health Insurance Legislation Amendment (Listing of Selpercatinib) Determination 2026 (F2026L01001)
Health Insurance (Section 4BA - Pathologist-Determinable Services) Amendment (Administrative) Determination 2026 (F2026L00986)
Health Insurance (Section 4BA - Pathologist-Determinable Services) Amendment (Ribonucleic Acid Testing for Hepatitis C) Determination 2026 (F2026L00413)
Health Insurance Legislation Amendment (Listing of Futibatinib) Determination 2026 (F2026L00632)
View Explanatory Statement/s